Skip to content

Pedal@Work: A Worksite Wellness Program

Pilot Study to Test the Efficacy of a Worksite Intervention for Reducing Daily Sedentary Time and Improving Risk Factors for Cardiometabolic Disease Among Sedentary, Overweight, Full-time Working Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01371084
Acronym
Pedal@Work
Enrollment
40
Registered
2011-06-10
Start date
2011-06-30
Completion date
2012-08-31
Last updated
2014-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Activity

Brief summary

The primary aim of this pilot study is to test the efficacy of a worksite intervention for reducing daily sedentary time and improving risk factors for cardiometabolic disease (e.g., measures of adiposity, anthropometrics, cardiorespiratory fitness) among sedentary, overweight, full-time working adults as compared to a waitlist control. A secondary aim will be to test pedal time at work as a measure of compliance with the intervention.

Detailed description

Recent research indicates prolonged sedentary behaviors such as computer use and workplace sitting are particularly damaging resulting in increased risk for chronic diseases such as cardiovascular disease, type 2 diabetes and obesity. Few interventions have been tested with the specific purpose of reducing sedentary time to improve risk factors for cardiometabolic diseases. The primary aim of this pilot study is to test the efficacy of a worksite intervention for reducing daily sedentary time and improving risk factors for cardiometabolic disease (e.g., measures of adiposity, anthropometrics, cardiorespiratory fitness) among sedentary, overweight, full-time working adults as compared to a waitlist control. A secondary aim will be to test pedal time at work as a measure of compliance with the intervention. Participants will be followed for 12 weeks and randomized to either a treatment or wait list control group which will have the option to crossover into the intervention after 12 weeks.

Interventions

BEHAVIORALPedal@Work Worksite Wellness

Participants randomized to the intervention group will be provided access to a portable pedal exercise machine, a pedometer and a worksite wellness motivational website for 12 weeks. As part of this website, participants will be emailed behavioral intervention materials a maximum of three times per week targeted at reducing sedentary time.

BEHAVIORALPedal@Work

Worksite wellness program.

Sponsors

East Carolina University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults between 21 and 65 years * Sedentary (engaging in moderate intensity physical activity for less than 60 minutes per week) * Working full time (35+ hours/week) at a sedentary desk dependant occupation * Overweight (Body Mass Index \> 25.0 kg/m2 but less than 40.0 kg/2) * Apparently healthy as assessed by a health history screening survey * Devoid of overt complicated or acute cardiovascular, metabolic, respiratory, or neurological diseases * Free from exercise/physical activity limitations

Exclusion criteria

* Adults with significant health problems exacerbated by exercise, such as uncontrolled hypertension, diabetes, orthopedic limitations, etc. will be excluded from the study. Note, with physician approval and adequate control of these health problems, these conditions will not necessarily preclude participation. * Being unable to exercise

Design outcomes

Primary

MeasureTime frameDescription
Step Watch - Physical Activity Minutes12 weeks between baseline and post-intervention follow upParticipants will wear a Step Watch monitor for 7 days at baseline and post-intervention. The intervention time period is 12 weeks.

Secondary

MeasureTime frameDescription
Cardiometabolic Risk12 weeks between baseline and post-intervention follow upCardiometabolic risk will be assessed by blood pressure, heart rate, cardiopulmonary fitness, lipids, waist circumference, BMI, and percent body fat

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026